This was comprised of $238 million in Jakafi net product revenue, $13 million in Iclusig net product revenue, $33 million in Jakavi royalties from Novartis and $43 million in contract revenue, including a milestone paid to us by Novartis, related to pricing approval of Jakavi for PV